Security key
05370A108
Atrium Therapeutics, Inc. - Common Stock (RNAM)
CUSIP: 05370A108
Q4 2024 13F Holders as of 31 Dec 2024
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 127,638,993
- Total 13F value
- $3,712,638,686
- Share change
- -561,378
- Put/Call ratio
- 139%
- SEC-reported price per share
- $29.08
- Number of holders
- 234
- Value change
- -$78,035,782
- Number of buys
- 120
- Number of sells
- 128
- Shares outstanding
- 150,858,761
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2024
Institutions
234
Top holders
10
Broader feeds
Ownership snapshot
Top reported holders of RNAM - Atrium Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
—
Disclosed value leader
—
Comparable rows
0/0
Latest evidence
—
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.
13F holder rows
Institutional holders as of Q4 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
234
Shares
127,638,993
Rows available
234
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
240
Q4 2024 holders
234
Holder diff
-6
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 value | Q4 2024 value | Value change | Value Chg % |
|---|